prof. Eva Van Braeckel

Journal Article
A1
open access

Amikacin Liposome Inhalation Suspension in Newly Diagnosed Mycobacterium avium Complex Lung Disease: A Phase 3b, Double-blind, Randomized Clinical Trial (ENCORE)

Charles L Daley, Kozo Morimoto, Rachel Thomson, Eva Van Braeckel (UGent) , Naoki Hasegawa, David E Griffith, Patrick A Flume, James D Chalmers, Kevin L Winthrop, Michael R Loebinger, et al.

(2026) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE.

Add to list

Journal Article
A1
open access

Clofazimine use for nontuberculous mycobacterial infections : 10-year experience in Belgium

Astrid Piot, Sophie Missault (UGent) , Yannick Vande Weygaerde (UGent) , Nityanand Jain, Pascal Van Bleyenbergh, Cedric Bosteels (UGent) , Isabel Spriet, Franky Buyle (UGent) , Eva Van Braeckel (UGent) and Natalie Lorent

(2026) BMC PULMONARY MEDICINE.

Add to list

Journal Article
A1
open access

Identification of DksA as a novel pro-inflammatory mediator of Pseudomonas aeruginosa under conditions mimicking chronic cystic fibrosis lung infection

Merel Wauters (UGent) , Laura Bollé (UGent) , Gilles De Meester (UGent) , Sara Van Den Bossche (UGent) , Lucia Grassi (UGent) , Delphi Van Haver (UGent) , Sara Dufour (UGent) , Simon Devos (UGent) , Francis Impens (UGent) , Eva Van Braeckel (UGent) , et al.

(2026) VIRULENCE. 17(1).

Add to list

Journal Article
A1
open access

Effects of elexacaftor/tezacaftor/ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis

Eva Van Braeckel (UGent) , Andrew T. Braun, Nicholas J. Simmonds, Peter J. Barry, Jane C. Davies, Marie E. Egan, Allen Lapey, Marcus A. Mall, Edward F. McKone, Daniel Peckham, et al.

(2026) JOURNAL OF CYSTIC FIBROSIS. 25(4). p.682-688

Add to list

Journal Article
A1
open access

Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function : insights from a European multicenter survey

Andrea Gramegna, Carlo Magnoni, Chiara Premuda, Gianfranco Alicandro, Onno Akkerman, Adelina Amorim, Pilar Azevedo, Stephen Bourke, Vincenzo Carnovale, Filia Diamantea, et al.

(2026) JOURNAL OF CYSTIC FIBROSIS. 25(4). p.628-636

Add to list

Journal Article
A2
open access

Pulmonary mycoses : a clinical perspective

Klara Verstappen (UGent) , Cedric Bosteels (UGent) and Eva Van Braeckel (UGent)

(2026) BREATHE. 22(1). p.1-12

Add to list

Book Chapter

Allergic bronchopulmonary aspergillosis

Ritesh Agarwal, Eva Van Braeckel (UGent) , Valliappan Muthu and Inderpaul Singh Seghal

(2026) Bronchiectasis. In European Respiratory Society Monograph p.125-147

Add to list

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population

Julie Semenchuk, Yumi Naito, Susan C Charman, Siobhán B Carr, Jamie Duckers, Stephanie Y Cheng, Bruce C Marshall, Albert Faro, Alexander Elbert, Christopher H Goss, et al.

(2026) JOURNAL OF CYSTIC FIBROSIS. 25(4). p.670-677

Add to list

Rethinking CFTR variant responsiveness : differential responses to vanzacaftor and elexacaftor

Noelia Rodriguez Mier, Isabelle Callebaut, Marijke Proesmans, Eva Van Braeckel (UGent) , Stephanie Van Biervliet (UGent) , Mieke Boon, Anabela Santo Ramalho and François Vermeulen

(2026) JOURNAL OF CYSTIC FIBROSIS. 25(2). p.314-318

Add to list

Histochemical staining underestimates peribronchial eosinophilic inflammation compared to ECP or GAL10 staining in human lung tissue

Yiannis De Meersman (UGent) , Iris Janssens (UGent) , Sebastian Riemann (UGent) , Joyceline De Volder (UGent) , Sara Wijnant, Eva Van Braeckel (UGent) , Bart Lambrecht (UGent) , Ken Bracke (UGent) , Guy Brusselle (UGent) and Tania Maes (UGent)

(2025) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. In American Journal of Respiratory and Critical Care Medicine 211(Supplement 1).

Academic Bibliography

prof. Eva Van Braeckel

Amikacin Liposome Inhalation Suspension in Newly Diagnosed Mycobacterium avium Complex Lung Disease: A Phase 3b, Double-blind, Randomized Clinical Trial (ENCORE)

Clofazimine use for nontuberculous mycobacterial infections : 10-year experience in Belgium

Identification of DksA as a novel pro-inflammatory mediator of Pseudomonas aeruginosa under conditions mimicking chronic cystic fibrosis lung infection

Effects of elexacaftor/tezacaftor/ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis

Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function : insights from a European multicenter survey

Pulmonary mycoses : a clinical perspective

Allergic bronchopulmonary aspergillosis

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population

Rethinking CFTR variant responsiveness : differential responses to vanzacaftor and elexacaftor

Histochemical staining underestimates peribronchial eosinophilic inflammation compared to ECP or GAL10 staining in human lung tissue

Contents

Support

Contact